Mindfulness in the treatment of chronic pain and improvement in the quality of life of both oncological and non-oncological patients
Journal Title: OncoReview - Year 2016, Vol 6, Issue 2
Abstract
Pain, which accompanies almost every third Pole, is an ever greater medical, psychological and social challenge. Relieving pain, and chronic one in particular, is now becoming one of the most important tasks for contemporary health care systems. It involves searching for efficacious therapeutic methods, not only with respect to pharmacotherapy, but also psychotherapy, physiotherapy, surgery, and a combination of those forms of treatment. Mindfulness is one of the newest modalities of cognitive behavioural therapy, and as a method that supports pharmacological pain management, it appears to be an interesting and efficacious way of reducing subjective pain experience in both oncological and non-oncological patients. It may also have a positive impact on the quality of life, reducing disease-related depressive symptoms and anxiety. Current study results encourage us to continue research in the field, and to further assess the efficacy of mindfulness trainings in different realms of medicine.
Authors and Affiliations
Anna Kieszkowska-Grudny
Keywords
Related Articles
- EP ID EP78745
- DOI 10.5604/20828691.1207990
- Views 204
- Downloads 0
Adjuvant imatinib after resection of gastrointestinal stromal tumour - systematic review and meta-analysis
[b]Background:[/b] Adjuvant therapy is recommended for population of patients with high risk of recurrence after resection of gastrointestinal stromal tumour.[b]The aim of the study:[/b] Evaluation of clinical efficacy a...
Mięsaki tkanek miękkich i kości oraz GIST – relacja z konferencji naukowej: ESMO Conference on Sarcoma and GIST, 9–10 marca 2012, Mediolan, Włochy
W dniach 9–10 marca 2012 r. w Mediolanie (Włochy) odbyła się konferencja naukowo-szkoleniowa zorganizowana przez Europejskie Towarzystwo Onkologii Medycznej (ESMO, European Society of Medical Oncology) poświęcona mięsako...
Placebo-Controlled, Double-Blind, Prospective, Randomized Study on the Effect of Octreotide LAR in the Control of Tumor Growth in Patients With Metastatic Neuroendocrine Midgut Tumors: A Report From the PROMID Study Group
Purpose: Somatostatin analogs are indicated for symptom control in patients with gastroenteropancreatic neuroendocrine tumors (NETs). The ability of somatostatin analogs to control the growth of well-differentiated metas...
Idiopathic venous thromboembolism or occult cancer?
The relationship between cancer and an increased incidence of venous thromboembolism (VTE) is well documented. VTE is a common complication of cancer, which usually occurs in the advanced stages of the disease. It often...
Powikłania zakrzepowo-zatorowe podczas hormonoterapii raka piersi - opis przypadku
69-letnia otyła kobieta po przebytej mastektomii lewostronnej i operacji oszczędzającej prawej piersi z powodu raka piersi, po przebytej chemio- i radioterapii, w trakcie uzupełniającej hormonoterapii przy użyciu tamoksy...